SOSV

Bill Liao

Biotech is possibly the most powerful tool our civilization possesses to make for a better world. Creating a successful biotech startup requires a nuanced approach that combines rigorous scientific research with astute business hustle. It is uniquely challenging, with high costs and long timelines for product development. Add in regulatory hurdles, and you have quite a tricky combination. Those who navigate these challenges successfully can literally ‘put a dent in the moon’ by making significant contributions to the environment, medicine, and healthcare while achieving financial success.

Science starts and ends with doubt. Without a doubt, there is no scientific method, and there is no rigor. A solid foundation in science is the keystone of any biotech startup. Without rigor at the core, you get Theranos. Now, while many successful biotech startups are spun out of academic research that has reached a point where it can be commercialized, the truth is that biotech has democratized to the point where many scientists are choosing to go straight to entrepreneurship, thus avoiding potentially ruinous university licensing fees. Still, founders need to stay engaged with state-of-the-art research and trends to be competitive and maintain a clear path to commercial application.

Equally important to success is honest hustle based on a contagious and well-communicated conviction. Without conviction, the entrepreneur cannot secure essential funding, and biotech startups require significant investment to cover research and development, clinical trials/regulatory, and path to market. Traditional venture capital is a common funding source, but it's also worth exploring grants, government funding, and partnerships with larger companies. These partnerships can provide not only funding but also valuable expertise and access to resources, and they don't work without an honest hustle.

Honest hustle is essential to forge another cornerstone of biotech success: an 'A' class team. Such teams of Entrepreneurs, scientists, and engineers, all with relevant expertise, stand the best chance of success and yet often, business development, regulatory affairs, and fundraising people do not naturally fit together. The complexity of bringing a biotech product to market requires a multifaceted team, and such a team needs to pull together. Two factors that can make that happen are resonant values and shared purpose. Yet, these factors are often overlooked both by scientists and by entrepreneurs.

Navigating the regulatory landscape is one of the most daunting aspects of running a biotech startup and is particularly concerning to investors as regulatory approval is a lengthy, complex process that varies significantly by geography, stage, and product. Understanding regulatory requirements from the outset is crucial for many reasons, and one of those is persuading investors that they will see new value inflection points with each regulatory hurdle that is overcome.

Another area of endeavor that is frequently ignored until too late is product market fit. Market Identifying and positioning are critical. Biotech startups need to identify a clear unmet need in the market and position their product to be a cost-effective solution. Particularly in environmental biotechnology, a thorough understanding of the competitive landscape and the needs of customers is essential to produce sustainable solutions. An unprofitable product is unsustainable.

"Agility and adaptability are key traits for biotech startups."

Agility and adaptability are key traits for biotech startups. The path from concept to market is rarely straightforward in biotech. Startups must be prepared to iterate their activity in response to new scientific findings, regulatory feedback, or changes in the market. This requires a culture of flexibility and a willingness to challenge assumptions and may also involve strategic patenting and IP management to protect the startup's innovations from competitors.

Another oft-overlooked area of any deep tech venture is communication and emotional storytelling, which are invaluable tools. Whether it is securing funding, navigating regulatory hurdles, or bringing a product to market, the ability to communicate the value and potential impact of the technology is crucial. This involves crafting an emotionally compelling, credible set of narratives that resonate with investors, regulators, and customers alike. It is a classic mistake to highlight only scientific innovation and not also the potential to change important things.

Having now witnessed the launch of many biotech startups, I can attest to the complexity and challenge at the same time. Companies such as Keel Labs, Cygenica, Cyclarity, and many more are delivering their founding team's enormous satisfaction, and while these endeavors are not for the faint of heart, they are a key way to upgrade our world and our civilization for the benefit of all.   By building a sturdy foundation in research, securing the right funding, assembling a talented team, navigating the regulatory landscape, identifying a clear market need, staying agile, and communicating effectively, those biotech entrepreneurs have proven able to overcome global challenges to make a significant impact in their fields.